Point-of-care testing (POCT) continues to gather momentum and grow at much faster rates than routine clinical laboratory testing. That’s the finding of analysts at Frost & Sullivan. In the United States, POCT product sales totaled $2.1 billion in 2009. Frost & Sullivan predicts that POCT sales will top $3.9 billion by 2016. It says the annual compounded growth rate of POCT products between 2006 and 2016 will be 9.2%. This compares with growth rates in the low single digits for routine tests, such as chemistry and hematology.
MORE ON: POCT
What are the hottest areas in point-of-care testing? According to Frost & Sullivan, in 2009, the big winners were POC influenza testing because of the 2009 H1N1 pandemic and POC coagulation patient self-monitoring, due to the 2008 Medicare reimbursement policy for patients with chronic atrial fibrillation and deep vein thrombosis. Going forward, Frost & Sullivan predicts that big market drivers will be POCT products for cardiac biomarkers, blood gas, and electrolytes.
FTC IS REVIEWING SALE OF WESTCLIFF TO LABCORP
Laboratory Corporation of America disclosed that its acquisition of Westcliff Medical Laboratories, Inc., is undergoing review by the Federal Trade Commission (FTC). The FTC is considering the anti-trust consequences of the acquisition. LabCorp says that it has entered into an agreement with the FTC to hold the WestCliff business unit as an independent laboratory called LabWest, during the FTC review. No date for the completion of the FTC review was announced. LabCorp paid $57.5 million to purchase California-based Westcliff Medical Laboratories, which had filed for Chapter 11 bankruptcy reorganization on May19. (See TDR, June 1, 2010.)
MAX PLANCK INSTITUTE BUILDING LAB IN FLORIDA
On June 23, ground was broken in Jacksonville, Florida, for a new research laboratory to serve the Max Planck Florida Institute. The new 100,000 square foot facility will be part of the John D. MacArthur campus of Florida Atlantic University. The Max Planck Florida Institute will conduct research in the areas of neuroscience and integrative biology.
Dark Daily Update
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about…
…why health insurers want to pre-authorize genetic and expensive molecular laboratory tests, along with how several of the nation’s largest payers are already excluding some local labs as providers.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.